The Mexican Competition Authority sanctions pharmaceutical companies for failing to comply with the commitments to restore competition in the pharma market (Moench Coöperatif / Luis Doporto Alejandre)

Competition Authority, Mexican

Article précédent The US FTC and DoJ publish final revised vertical merger guidelines Article suivant The US DoJ and FTC issue a revised version of the vertical merger guidelines

30 Jun 2020

The Mexican Competition Authority sanctions pharmaceutical companies for failing to comply with the commitments to restore competition in the pharma market (Moench Coöperatif / Luis Doporto Alejandre)

KEYWORDS

Reference

Mexican Competition Authority, Moench Coöperatif / Luis Doporto Alejandre, Press release, 30 June 2020

COFECE sanctions Moench Coöperatif and Luis Doporto for failing to comply with the commitments made to totally and permanently eliminate any possible link between Nadro and Marzam, in the market for the distribution of pharmaceutical products* The commitments were accepted by the Board of Commissioners of COFECE in June 2018, thus the Investigative Authority closed the file for probable unlawful concentration. For breaching the commitments, Moench and Luis Doporto Alejandre are sanctioned with fines amounting 30 million 893 thousand Mexican pesos, also they must prove

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

Version PDF

Auteur

Mexican Competition Authority
Mexican Competition Authority (Mexico City)

Mexique 130 contributions 25005 visites

Citation

Mexican Competition Authority, The Mexican Competition Authority sanctions pharmaceutical companies for failing to comply with the commitments to restore competition in the pharma market (Moench Coöperatif / Luis Doporto Alejandre), 30 juin 2020, e-Competitions June 2020, Art. N° 95657

Visites 220